跳至主要内容
临床试验/CTRI/2016/10/007336
CTRI/2016/10/007336尚未招募未知

To Compare the Efficacy of Ulipristal Acetate versus GnRH Agonist in Women with Symptomatic Uterine Myoma and Post treatment Follow Up : A Prospective Randomized Control Study - CAGE

ot Applicable0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
ot Applicable
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age group: 21 to 49 years of age.
  • 2.Uterus size <= 18 weeks on bimanual examination.
  • 3.Ultrasonography suggestive of at least one uterine myoma of >= 3 cm diameter in size.
  • 4.Provide informed written consent.

排除标准

  • 1.Uterine size > 18 weeks on clinical examination.
  • 2.Any single myoma size > 10 cm on ultrasonography.
  • 3.Treatment with any hormonal preparation within 3 months of recruitment.
  • 4.History of myomectomy.
  • 5.History of uterine artery embolization.
  • 6.Known case of uncontrolled thyroid disorders, liver disease, hemoglobinopathy coagulation disorder.
  • 7.Large uterine polyp ( >2 cm), Submucosal fibroid (class 0 under myoma sub classification system).
  • 8.Ovarian cysts >=4 cm in diameter as measured by ultrasound.
  • 9.Suspected or known case of gynecological cancer/atypical endometrial hyperplasia

研究者

发起方
ot Applicable

相似试验